At the end of 2020, experts led by allergists at Massachusetts General Hospital (MGH) examined all information related to possible allergic reactions to COVID-19 vaccinations. Now the team has published updated insights based on their experience overseeing more than 65,000 employees who have become fully vaccinated since that time. The group’s latest findings are published in the Journal of Allergy and Clinical Immunology: In Practice.
“Our main goal is to enable as many individuals as possible to receive a COVID-19 vaccine safely and avoid unnecessary vaccine hesitancy due to a lack of knowledge around allergic reactions to vaccines,” says lead author Aleena Banerji, MD, clinical director of the Allergy and Clinical Immunology Unit at MGH.
In addition to updated guidance on the Pfizer-BioNTech and Moderna COVID-19 vaccines, this guidance also includes the Janssen COVID-19 vaccine, which had not yet been authorized for emergency use at the end of 2020.
With additional clinical data and authorization of the third COVID-19 vaccine in the United States, the investigators propose modified approaches to the evaluation of patients with a history of allergies. This includes clear and simple initial questions to identify individuals who are eligible for all COVID-19 vaccines without needing an allergist evaluation.
“With more time and experience, we have been able to significantly narrow the group of patients with prior allergies who require an allergist assessment before COVID-19 vaccination,” says senior author Kimberly G. Blumenthal, MD, MSc, co-director of the Clinical Epidemiology Program within MGH’s Division of Rheumatology, Allergy and Immunology. “We now advise that only the rare individuals who have had a recent severe allergic reaction to polyethylene glycol, an ingredient in the vaccines, see an allergist or immunologist for evaluation, which may include skin testing.” Individuals with severe allergies to foods, oral drugs, latex, bee stings or venom can safely receive the COVID-19 vaccines.
The team noted that severe allergic reactions to the vaccines remain exceedingly rare. Vaccine clinics should continue to observe higher-risk individuals for 30 minutes after vaccination, and they should have staff trained in recognizing and managing allergic reactions that may occur.
- Aleena Banerji, Anna R. Wolfson, Paige G. Wickner, Amelia S. Cogan, Aubree E. McMahon, Rebecca Saff, Lacey B. Robinson, Elizabeth Phillips, Kimberly G. Blumenthal. COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach. The Journal of Allergy and Clinical Immunology: In Practice, 2021; DOI: 10.1016/j.jaip.2021.03.053
Iran hits record for new COVID-19 cases for second day running
Explainer: US pays $4 bln to Afghan forces; Who is watching?
Mac Neil wins Canada’s first gold in Tokyo Games first in women’s 100 butterfly
Tunisian president relieves prime minister of his post, freeze parliament
Algeria reimposes restrictions on gatherings to stem COVID-19 cases
Asia7 days ago
India’s COVID-19 excess deaths surpass four million: research
Latin America7 days ago
Haiti arrests 3 cops, awaits new chief, while mourning Moise
Asia5 days ago
Man with coronavirus disguises as wife on Indonesian flight
U.S7 days ago
Extreme weather fuels Oregon wildfires; outside help sought
Europe5 days ago
Norway mourns 77 dead a decade after extremist attack
Middle East5 days ago
Israel to reimpose COVID-19 ‘Green Pass’ as Delta variant hits
Australia & NZ4 days ago
Sydney COVID-19 outbreak a ‘national emergency’ as cases spike
Health5 days ago
Europe Could Have Been Hit With COVID-19 Earlier Than China, New Study Reveals